Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl
Preferences help
Polish version English version Language
enabled [disable] Abstract
Number of results

Results found: 2

Number of results on page
first rewind previous Page / 1 next fast forward last

Search results

help Sort By:

help Limit search:
first rewind previous Page / 1 next fast forward last
1
Publication available in full text mode
Content available

The role of interdisciplinary cooperation in the prevention of medication-related osteonecrosis of the jaw (MRONJ)

100%
Teślak M., Chlebus I., Ordyniec-Kwaśnica I.
|
2020
|
vol. 3
|
issue 1
60-65
EN
Medication-related osteonecrosis of the jaw (MRONJ) is considered one of the most severe complications of treatment with antiresorptive drugs. The number of patients with MRONJ has significantly increased due to the broadening of the indication to treat with bisphosphonates and other antiresorptive drugs (e.g. denosumab). Because MRONJ has a significant impact on the patients’ quality of life, it is necessary to reduce the risk of such complications by implementing preventive measures, e.g. full dental and oral cavity examination for all patients qualified for treatment with angiogenesis inhibitors or antiresorptive drugs.
2
Publication available in full text mode
Content available

The role of interdisciplinary cooperation in the prevention of medication-related osteonecrosis of the jaw (MRONJ)

100%
Teślak M., Chlebus I., Ordyniec-Kwaśnica I.
European Journal of Translational and Clinical Medicine
|
2020
|
vol. 3
|
issue 1
60-65
EN
Medication-related osteonecrosis of the jaw (MRONJ) is considered one of the most severe complications of treatment with antiresorptive drugs. The number of patients with MRONJ has significantly increased due to the broadening of the indication to treat with bisphosphonates and other antiresorptive drugs (e.g. denosumab). Because MRONJ has a significant impact on the patients’ quality of life, it is necessary to reduce the risk of such complications by implementing preventive measures, e.g. full dental and oral cavity examination for all patients qualified for treatment with angiogenesis inhibitors or antiresorptive drugs.
first rewind previous Page / 1 next fast forward last
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.